<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000410746"><TermName>Hycamtin</TermName><TermPronunciation>(hy-KAM-tin)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat certain types of ovarian cancer, lung cancer, and cervical cancer. Hycamtin is a type of topoisomerase inhibitor. Also called topotecan and topotecan hydrochloride.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713287" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Hycamtin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713286" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Hycamtin&quot;" language="es" id="_4"/><SpanishTermName>Hycamtin</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento usado para tratar ciertos tipos de cáncer de ovario, de pulmón y de cuello uterino. Hycamtin es un tipo de inhibidor de la topoisomerasa. También se llama clorhidrato de topotecán y topotecán.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-03-24</DateFirstPublished><DateLastModified>2007-06-19</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000495675">Topotecan Hydrochloride</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
